Yılmaz, I. T. Et Al. 2022. Therapeutic efficacy of vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) in amyotrophic lateral sclerosis (ALS) mouse model. The International Symposium on VIP, PACAP and Related Peptides (VPAC) , (Osaka, Japan).

Yılmaz, I. T., KORKMAZ, O. T., KUŞ, G., ÖNCÜ KAYA, E. M., MERAL EVİŞ, C. C., ESER, M., ... ULUPINAR, E.(2022). Therapeutic efficacy of vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) in amyotrophic lateral sclerosis (ALS) mouse model . The International Symposium on VIP, PACAP and Related Peptides (VPAC), Osaka, Japan

Yılmaz, Işıl Et Al. "Therapeutic efficacy of vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) in amyotrophic lateral sclerosis (ALS) mouse model," The International Symposium on VIP, PACAP and Related Peptides (VPAC), Osaka, Japan, 2022

Yılmaz, Işıl T. Et Al. "Therapeutic efficacy of vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) in amyotrophic lateral sclerosis (ALS) mouse model." The International Symposium on VIP, PACAP and Related Peptides (VPAC) , Osaka, Japan, 2022

Yılmaz, I. T. Et Al. (2022) . "Therapeutic efficacy of vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) in amyotrophic lateral sclerosis (ALS) mouse model." The International Symposium on VIP, PACAP and Related Peptides (VPAC) , Osaka, Japan.

@conferencepaper{conferencepaper, author={Işıl Tan Yılmaz Et Al. }, title={Therapeutic efficacy of vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) in amyotrophic lateral sclerosis (ALS) mouse model}, congress name={The International Symposium on VIP, PACAP and Related Peptides (VPAC)}, city={Osaka}, country={Japan}, year={2022}}